RDNT

RadNet, Inc.

$77.94

-0.56%
SectorHealthcareIndustryDiagnostics & ResearchCountryUnited States

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening.

Source: Yahoo Finance
AI summary

Price & performance

1M+9.9%
3M+0.9%
YTD+9.9%
1Y-3.6%
52-week range—
Beta1.21
Full chart and returns against a benchmark

Q-Score

63/ 100

Quality against peers; 50 is the peer median.

Growth66
Risk66
Performance64
Valuation54
Profitability57
Leverage42
Sentiment40
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$2B+11.5%
Net income-$18.7M-767.8%
Net margin-0.9%-1.1 pts
Historical fundamentals

Revenue exposure

2%of revenue from outside the US
United States98%
Non Us2%
Regions, segments, customers and suppliers

Valuation

RDNTIndustryP/E—41.31P/S2.575.66EV/EBITDA26.7931.63P/B5.484.91PEG—3.59
Dividend yield0.00%
Every valuation metric

Earnings

Nov 8next report, after the close
EPS estimate$0.22
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate